Increasing Prevalence of Cardiovascular and Psychological Diseases is Projected to Fuel Market Expansion
The increasing prevalence of neurological, psychological and other speech-related diseases, such as depression, attention deficit and behavioural issues, Alzheimer's disease, Parkinson's disease (PD), Huntington’s disease, respiratory, cardiovascular, and brain injury (TBI), are driving the global vocal biomarkers market. As reported by the WHO, cardiovascular diseases (CVDs) are the leading cause of death globally, claiming an estimated 17.9 million lives each year, a number that is anticipated to rise to 23.6 million by 2030. According to the Pan American Health Organization, neurological diseases caused 533,172 fatalities in 2022. Moreover, the National Library of Medicine reports that an estimated 6.5 million Americans aged 65 and older are living with Alzheimer's disease currently. This figure is expected to rise to 13.8 million by 2060, demanding rapid research into biomarkers for early diagnosis of Alzheimer's disease. Additionally, vocal biomarker technology devices would be an ideal low-cost first diagnostic tool that might assist in determining whether the patient requires more expensive X-ray/MRI/CT/EEG/ECG tests. As a result of the enormous number of people suffering from various chronic diseases, there is a significant commercial potential for vocal biomarkers technology in the long term. Furthermore, conventional diagnostic systems must follow severe radiation regulations, but voice-based systems are based on technology that does not emit any type of radiation and is thus likely to gain significant traction throughout the forecast period.
Increasing Awareness for Minimally Invasive Surgery is Projected to Propel the Vocal Biomarkers Market Forward
Rising investments in healthcare R&D, a growing focus on advanced diagnostic procedures, an increase in the popularity of non-invasive surgical treatments, supportive government initiatives, rapid advancement in biomarker technology and faster adoption of advanced technologies such as machine learning and AI in medical applications are key factors expected to drive future demand for vocal biomarkers. Over the forecast period, rising demand for remote monitoring of patient solutions is likely to generate a very profitable business opportunity for vocal biomarker manufacturers. For instance, Sonde Health, a PureTech Health Spinout and manufacturer of vocal biomarker technology, announced a collaboration with Qualcomm Technologies in July, 2022. Sonde's machine learning vocal biomarker capabilities will be combined with Qualcomm's Snapdragon 888 and 778G 5G mobile platforms to provide medical screening and monitoring applications to mobile devices that use the platform. Such teamwork and progress will result in better solutions and more accurate results for patients. It will encourage researchers and organisations all around the world to collect voice data in order to enhance patient outcomes and diagnoses. This type of new technology, as well as the advancement of players, is giving the industry a significant boost.
Recent Trends in Vocal Biomarker Market;
- Rapid innovations in AI and machine learning are enhancing the accuracy.
- Growing interest from healthcare providers and researchers.
- Integration of vocal biomarker technology with wearable devices is expanding its application.
- Emerging regulations and standards are shaping the development.
- Enhanced focus on developing personalized vocal biomarker solutions.
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
High Pricing of these Technologies May Be Considered as One of The Most Significant Market Challenges
Significant flaws in vocal characteristics and word boundary inconsistencies may stymie the global vocal biomarkers market's growth. Many patients in developing countries cannot afford minimally invasive technology such as MRI, CT, X-ray and ECG. Additionally, individuals choose less invasive procedures because of advantages such as faster recovery. However, the high costs of these approaches may be considered as one of the most important obstacles for the global vocal biomarker market. This expensive cost not only limits the market to a specific group but also hinders healthcare providers and patients from fully taking advantage of these new solutions. Due to these financial constraints, it is difficult to achieve wider market penetration and fully leverage the potential of vocal biomarkers.
Collaboration Between Technology Developers, Healthcare Providers, and Research Institutions is Driving the Market Expansion Of Vocal Biomarkers
Partnership among technology developers, healthcare providers, and research institutions is fuelling market growth for vocal biomarkers. These partnerships help incorporate cutting-edge vocal biomarker technologies into medical practice and encourage the creation of creative solutions. By bringing together knowledge from diverse fields, collaborations quicken research progress, enrich product selections, and enhance availability. For instance, Canary Speech announced a partnership with SMK and Japan's National Cerebral and Cardiovascular Center (NCVC) in April 2022 to develop and validate AI speech algorithms for early diagnosis of MCI and dementia, as well as other diseases in Japanese, such as anxiety and depression. This cooperative method enhances vocal biomarker technology and expands its market penetration, leading to increased growth and acceptance in the healthcare sector.
Know Your Competitors and Strengthen Market Share Effectively
Raising Public Awareness of the Use of Voice Analysis Technologies for Health Care Provides a Lucrative Market Potential
An increasing number of psychological issues are projected to push North America to dominate the global vocal biomarker market. According to the Alzheimer's Association, more than 6 Mn People have Alzheimer's disease. This number is projected to climb to approximately 13 Mn by 2050, requiring more rapid research into biomarkers for early detection of Alzheimer's disease. Moreover, medical reimbursement laws and growing healthcare costs in the region support market expansion. Furthermore, due to rising healthcare costs and increased awareness in the region, Europe is the second-largest region in the global vocal biomarkers market. People in the European region are becoming more aware of the use of artificial intelligence (AI) for sound analysis for risk prediction, diagnostic and remote monitoring of various clinical outcomes and symptoms, as well as for health-related purposes. As a result, artificial intelligence (AI)-based voice analysis, such as vocal biomarkers, has created novel possibilities for the European healthcare sector. As a result, several firms are focused on the release of new voice analysis technology solutions.
Searching for a Country or Region-Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
The report provides a detailed overview of the vocal biomarker market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for vocal biomarker market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the vocal biomarker market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the vocal biomarker market. Some key country and region included in the vocal biomarker market report as follows:
| Regions | Countries |
|---|---|
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Vocal Biomarker Market Research Report Covers In-depth Analysis on:
- Vocal biomarker market detailed segments and segment-wise market breakdown
- Vocal biomarker market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in vocal biomarker industry)
- Current, historical and forthcoming 10 years market valuation in terms of vocal biomarker market size (US$ Mn), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Vocal biomarker market demand analysis
- Vocal biomarker market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in vocal biomarker market
- Regulatory landscape by key regions and key countries
- Vocal biomarker market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on vocal biomarker market forecast by countries
- Mergers and acquisitions in vocal biomarker market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
How is the vocal biomarker market expected to grow in the next decade?
The vocal biomarker market is projected to experience significant growth, driven by advancements in AI and voice recognition technologies, along with increased applications in healthcare and telemedicine.
What factors are driving the demand for vocal biomarkers?
The growing focus on remote health monitoring, the rising prevalence of mental health issues and advancements in AI technology are key factors driving demand in the vocal biomarker market.
How can businesses benefit from vocal biomarker research?
Businesses can leverage vocal biomarker research to improve customer engagement, enhance mental health support services, and develop innovative products that utilize voice data for personalized experiences.
